Stereotaxis, Inc. (STXS) is a leading healthcare technology and innovator company that is globally recognized for its significant contribution towards developing robotic technologies for the treatment of arrhythmias, a group of conditions characterized by irregular heartbeats. Headquartered in St. Louis, Missouri, Stereotaxis stands at the forefront of medical robotics and runs operations all over the world, providing a robotic technology platform that enhances the treatment of cardiac arrhythmias.
The company operates with the sole vision of helping medical professionals treat people with arrhythmias more efficiently and effectively. Stereotaxis applies robotic precision to interventional procedures, revamping the landscape of electrophysiology, which is the study of the electrical properties of the heart. Its innovative technologies, the Stereotaxis Robotic Magnetic Navigation (RMN) system and Stereotaxis Genesis RMN system, are some of the leading products in the market.
The Stereotaxis RMN system is a technological marvel renowned for its precision and safety advancements. Comprising two magnets controlled by a computer system, it manipulates the magnetic field to guide a medical tool across the complex and delicate pathways within the heart in a soft and consistent manner, thus reducing the risk of complications.
On the other hand, the Stereotaxis Genesis RMN system is another leap forward in technological advancement. It aims to provide high operational efficiency, improve clinical capabilities, and support advanced technological integration.
Moreover, Stereotaxis's robust product portfolio includes related software solutions and devices designed to enhance the utility of existing technology in the field. This has led to a network of hundreds of patented innovations that are transforming interventional medicine.
The revolutionary work of Stereotaxis is recognized globally, and its products are used by physicians in over 100 hospitals across the world. Today, these innovations have been applied in over 100,000 clinical procedures.
The company’s success is powered by their commitment to delivering comprehensive solutions that enable medical professionals to offer the most advanced care in electrophysiology. Through continuous research and development, Stereotaxis is consistently raising the bar in the field of medical robotics.
Stereotaxis, Inc. is distinguished by its commitment to clinical excellence, continuous innovation, and dedication to improving patient health outcomes. This unique attribute has carved a prominent place for Stereotaxis in the world’s healthcare technology industry, making it a figurehead in the realm of robotic innovation.